AnandRathi

Parmax Pharma Ltd Fundamental Analysis

Last Updated Date: 24 Aug 2026
131.15
+1.25 (+0.96%)

Parmax Pharma Ltd (Parmax Pharma) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹49 crore.

Parmax Pharma Ltd Overview

Market cap₹49 Crs
Volume54,997
Prev. Close₹129.90
Year range₹22.60 - ₹131.15
Total Value₹72,12,856.55
ISININE240T01014

Parmax Pharma Ltd Fundamental Analysis

ROCE(TTM)-85.76%
P/E Ratio (TTM)-41.11
P/B Ratio0.00
Debt to Equity-1.87
ROE67.65%
EPS (TTM)0.00
Dividend Yield0.00%
Book Value-18.33
Profit Margin-6.47%
Operating Margin-20.45%

Parmax Pharma Ltd Historical Performance

1 Month Return27.54%
6 Month Return336.15%
3 Year Return340.40%
3 Month Return257.26%
1 Year Return269.44%
5 Year Return237.58%

Parmax Pharma Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research